Detect
PrivateLast Round
Series B
Jul 14, 2022
Est. Valuation
$140M
Total Funding Raised
$62.3M
Company Overview
Detect is a biotechnology company that develops a molecular diagnostic testing platform designed to provide rapid, accurate, and accessible diagnostic results at the point of need.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, D2C Brands, Consumer Electronics
Business Model
B2C
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Detect Comparables
Compare Detect with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aptitude Medical | 85% | |
| Visby Medical | 81% | |
| Prominex, Inc. | 81% |
Detect Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 14, 2022 | ||||
| Grant | Feb 8, 2022 | ||||
| VC Round | Dec 15, 2021 | ||||
| Grant | Oct 14, 2021 | ||||
| VC Round | Jun 30, 2021 | ||||
Series A | Nov 21, 2018 |
Key People
Founding team and executive leadership
Detect Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Department of Health and Human Services | Grant |
| Keiretsu Forum | Seed, Series A |
| IIT Madras Incubation Cell | Seed |
| NIH RADx | Grant |
| Stride Ventures | VC Round |
| Shell Ventures | Series B |
| Foresite Capital | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 14, 2021
Received $8.1M from NIH RADx and HHS.
- Nov 21, 2018
$3.3M round led by Elevation Capital.
Recent news
Latest coverage and updates
- is_developingSep 4, 2026
Detect is developing rapid diagnostic test for Crimean-Congo haemorrhagic fever on Sep 4th '26.
Detect Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Detect's valuation, stock price, and market status.
Is Detect a public or private company?
Detect is a private company.
What is the current stock price of Detect?
Detect is a private company with no public stock price. No recent secondary market data is available.
How much is Detect worth (valuation)?
Valuation information for Detect is not publicly available.
Can I buy Detect stock?
Detect shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Detect's last funding round?
Detect's most recent funding round was Grant on February 8, 2022.
Who are the main investors in Detect?
Key investors in Detect include NIH RADx, Biomedical Advanced Research and Development Authority.
Will Detect IPO soon?
No public IPO plans have been announced for Detect.
How can I track Detect secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Detect's secondary market activity and sign up for updates.